Joy Fisher

3.8k total citations · 1 hit paper
56 papers, 2.6k citations indexed

About

Joy Fisher is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joy Fisher has authored 56 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 23 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joy Fisher's work include Glioma Diagnosis and Treatment (46 papers), Brain Metastases and Treatment (18 papers) and Cancer Treatment and Pharmacology (13 papers). Joy Fisher is often cited by papers focused on Glioma Diagnosis and Treatment (46 papers), Brain Metastases and Treatment (18 papers) and Cancer Treatment and Pharmacology (13 papers). Joy Fisher collaborates with scholars based in United States, Switzerland and Australia. Joy Fisher's co-authors include Stuart A. Grossman, Steven Piantadosi, Serena Desideri, Xiaobu Ye, Burt Nabors, Kathryn A. Carson, Myrna R. Rosenfeld, Tom Mikkelsen, Edward G. Shaw and Glenn J. Lesser and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Joy Fisher

54 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

2014 409 citations Myrna R. Rosenfeld, Xiaobu Ye et al. Autophagy profile →

Peers

Countries citing papers authored by Joy Fisher

Since Specialization

Citations

This map shows the geographic impact of Joy Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Fisher more than expected).

Fields of papers citing papers by Joy Fisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Fisher. The network helps show where Joy Fisher may publish in the future.

Co-authorship network of co-authors of Joy Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Joy Fisher. A scholar is included among the top collaborators of Joy Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Fisher. Joy Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma 2024 ·Clinical Cancer Research ·Karisa C. Schreck, Roy E. Strowd, Burt Nabors, Benjamin M. Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth Aldape, (unknown), Serena Desideri, Joy Fisher, (unknown), (unknown), Michelle A. Rudek, Chetan Bettegowda, Stuart A. Grossman, Xiaobu Ye	7
2	144 (PB132): JNJ-79032421 is a novel membrane restricted mesothelin targeting Tcell engaging bispecific antibody for treatment of mesothelin-positive cancers 2024 ·European Journal of Cancer ·Karine Smans, (unknown), (unknown), (unknown), (unknown), (unknown), Katrin Sproesser, (unknown), Kathryn Packman, Joy Fisher, (unknown), Ted Petley, Esther W. Chan, (unknown), (unknown), Matthew V. Lorenzi, Sheri L. Moores, Jeff Clawson, Sylvie Laquerre	0
3	ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449 2022 ·Journal of Neuro-Oncology ·Andrew E. Sloan, Charles Nock, Xiaobu Ye, (unknown), Susan M. Chang, Glenn J. Lesser, Andrew D. Norden, Timothy F. Cloughesy, Jeffrey J. Olson, Amber Kerstetter-Fogle, Jeremy N. Rich, Joy Fisher, Serena Desideri, Naoko Takebe, William C. Timmer, Stuart A. Grossman, Michael D. Prados	9
4	Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas 2017 ·Neuro-Oncology ·Matthias Holdhoff, Xiaobu Ye, Jeffrey G. Supko, Burt Nabors, Arati Desai, Tobias Walbert, Glenn J. Lesser, William L. Read, Frank S. Lieberman, Martin A. Lodge, Jeffrey P. Leal, Joy Fisher, Serena Desideri, Stuart A. Grossman, Richard L. Wahl, David Schiff	43
5	Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas 2017 ·Journal of Neuro-Oncology ·Lakshmi Nayak, John de Groot, Jeffrey S. Wefel, Timothy F. Cloughesy, Frank S. Lieberman, Susan M. Chang, Antonio Omuro, Jan Drappatz, Tracy T. Batchelor, Lisa M. DeAngelis, Mark R. Gilbert, Kenneth Aldape, Alfred Yung, Joy Fisher, Xiaobu Ye, Alice P. Chen, Stuart A. Grossman, Michael D. Prados, Patrick Y. Wen	23
6	Repeatability of ¹⁸F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma 2016 ·Journal of Nuclear Medicine ·Martin A. Lodge, Matthias Holdhoff, Jeffrey P. Leal, Asim K. Bag, Burt Nabors, Akiva Mintz, Glenn J. Lesser, David A. Mankoff, Arati Desai, James M. Mountz, Frank S. Lieberman, Joy Fisher, Serena Desideri, Xiaobu Ye, Stuart A. Grossman, David Schiff, Richard L. Wahl	23
7	A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors 2015 ·Journal of Neuro-Oncology ·Michael B. Streiff, Xiaobu Ye, Thomas S. Kickler, Serena Desideri, Jayesh Jani, Joy Fisher, Stuart A. Grossman	66
8	A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme breakdown → 2014 ·Autophagy ·Myrna R. Rosenfeld, Xiaobu Ye, Jeffrey G. Supko, Serena Desideri, Stuart A. Grossman, Steven Brem, Tom Mikkelson, Daniel Wang, Yunyoung C Chang, (unknown), Quentin McAfee, Joy Fisher, Andrea B. Troxel, Shengfu Piao, Daniel F. Heitjan, (unknown), Laura Pontiggia, Peter J. O’Dwyer, Lisa E. Davis, Ravi K. Amaravadi	409
9	Imaging biomarkers of ramucirumab and olaratumab in patients with recurrent glioblastoma. 2013 ·Journal of Clinical Oncology ·Jaishri O. Blakeley, Joy Fisher, Frank S. Lieberman, Janine Lupo, Burt Nabors, Jason C. Crane, Patrick Y. Wen, (unknown), David M. Peereboom, Qiuting Wen, Timothy F. Cloughesy, H. Ian Robins, Serena Desideri, Stuart A. Grossman, Xiaobu Ye, Sarah J. Nelson	4
10	A safety run‐in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306) 2012 ·Cancer ·Burt Nabors, T. Mikkelsen, Monika E. Hegi, (unknown), Tracy T. Batchelor, Glenn J. Lesser, David M. Peereboom, Myrna R. Rosenfeld, (unknown), (unknown), Joy Fisher, Stuart A. Grossman	102
11	Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas 2011 ·Journal of Neuro-Oncology ·Michelle A. Rudek, Pamela New, Tom Mikkelsen, Surasak Phuphanich, Jane Β. Alavi, Burt Nabors, Steven Piantadosi, Joy Fisher, Stuart A. Grossman	18
12	A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas 2010 ·Journal of Neuro-Oncology ·David M. Peereboom, Jeffrey G. Supko, Kathryn A. Carson, Tracy T. Batchelor, Surasak Phuphanich, Glenn J. Lesser, Tom Mikkelson, Joy Fisher, Serena Desideri, (unknown), Stuart A. Grossman	18
13	Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial 2009 ·Journal of Clinical Oncology ·Stuart A. Grossman, Xiaobu Ye, Marc C. Chamberlain, Tom Mikkelsen, Tracy T. Batchelor, Serena Desideri, Steven Piantadosi, Joy Fisher, Howard A. Fine	131
14	Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma 2008 ·Neuro-Oncology ·Surasak Phuphanich, Kathryn A. Carson, Stuart A. Grossman, Glenn J. Lesser, Jeffrey J. Olson, Tom Mikkelsen, Serena Desideri, Joy Fisher	18
15	Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiforme 2006 ·Investigational New Drugs ·Tom Mikkelsen, Richard M. Lush, Stuart A. Grossman, Kathryn A. Carson, Joy Fisher, Jane Β. Alavi, Steve Rosenfeld	26
16	Phase 2 trial of copper depletion and penicillamine as antiangiogenesistherapy of glioblastoma 2005 ·Neuro-Oncology ·Steven Brem, Stuart A. Grossman, Kathryn A. Carson, Pamela New, Surasak Phuphanich, Jane Β. Alavi, Tom Mikkelsen, Joy Fisher	107
17	Oral sodium phenylbutyrate in patients with recurrent malignant gliomas:A dose escalation and pharmacologic study 2005 ·Neuro-Oncology ·Surasak Phuphanich, Sharyn D. Baker, Stuart A. Grossman, Kathryn A. Carson, Mark R. Gilbert, Joy Fisher, Michael A. Carducci	75
18	Toxicity, Efficacy, and Pharmacology of Suramin in Adults With Recurrent High-Grade Gliomas 2001 ·Journal of Clinical Oncology ·Stuart A. Grossman, Surasak Phuphanich, Glenn J. Lesser, Jack M. Rozental, Louise B. Grochow, Joy Fisher, Steven Piantadosi	44
19	Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosedglioblastoma multiforme and recurrent high-grade astrocytoma 2000 ·Neuro-Oncology ·Fred H. Hochberg, Stuart A. Grossman, Tom Mikkelsen, Michael Glantz, Joy Fisher, Steven Piantadosi	12
20	Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants 1998 ·Cancer Chemotherapy and Pharmacology ·Stuart A. Grossman, Fred H. Hochberg, Joy Fisher, (unknown), Lyndon Kim, R E Gregory, Louise B. Grochow, Steven Piantadosi	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact